Search
for
Sort by
Research 271–300 of 1000+
- The first case report of kerion-type scalp mycosis caused by Aspergillus protuberus
- Alopecia areata – Current understanding and management
- Controversy: Synthetic hairs and their role in hair restoration?
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Hair diseases: a big problem on a small surface
- <i>In Vivo</i>Evaluation of<i>Galla chinensis</i>Solution in the Topical Treatment of Dermatophytosis
- Caution with Hair Dye: Foreign Body Skull Erosive Granuloma from Exogenous Hair Pigmentation
- South Asian Epidemic of Antifungal Therapeutic Failures: Congress Proceedings and Take-home Messages. First International Congress of SAARCUM: South Asian Alliance against Recalcitrant Cutaneous Mycosis. 17 November 2018, Medanta – The Medicity, Gurugram, India
- A Current Diagnostic and Therapeutic Challenge: Tinea Capitis
- Multicenter clinical study on biocompatible artificial hair
- Cutaneous manifestations associated with substance use disorders
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Consensus report on the use of PN‐HPT™ (polynucleotides highly purified technology) in aesthetic medicine
- Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta‐Analysis
- Hirsutism-A Comprehensive Update of Embryology, Aetiopathogenesis and Therapeutic Approach
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Hair and diabetes
- Pediatric Tinea Capitis
- JAK Inhibitors for Treatment of Alopecia Areata
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Disinfection, sterilization and operation theater guidelines for dermatosurgical practitioners in India
- COVID-19 and hypopituitarism
- Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
- Complications of Self‐Injected Facial Fillers: A Treatment Conundrum in the UK
- Expert recommendations on supportive skin care for non‐surgical and surgical procedures
- Janus kinase inhibitors for alopecia areata: A narrative review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review